Major depressive disorder trials recruiting in Maryland

All Major depressive disorder trials nationally

Cities in Maryland

Recruiting trials in Maryland

• A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
  NCT07115329 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · Maryland: Rockville, Towson
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
  NCT07076407 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Maryland: Baltimore
• Defining Neurobiological Links Between Substance Use and Mental Illness
  NCT05538910 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · Maryland: Baltimore
• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06966401 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Gaithersburg
• Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
  NCT03973268 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Maryland: Bethesda
• NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06963021 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Gaithersburg
• Natural History of Depression, Bipolar Disorder and Suicide Risk
  NCT06462196 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
  NCT03065335 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Bethesda
• Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
  NCT00018057 · Phase: Phase 2 · Ages: 8 Years to 65 Years · Sex: All (male and female) · Maryland: Bethesda, College Park